Aktie A2P91J LINCOLN PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Lincoln Pharmaceuticals Limited NSE India S.E.

Aktien

A2P91J

INE405C01035

LINCOLN

Verzögert NSE India S.E.
Andere Börsenplätze
 13:42:30 30.04.2024 		% 5 Tage % 1. Jan.
604,6 INR +1,78 % Intraday Chart für Lincoln Pharmaceuticals Limited +2,34 % -0,80 %
30.03. Lincoln Pharmaceuticals Limited gibt bekannt, dass Pirabhai Suthar seine Tätigkeit als unabhängiges Verwaltungsratsmitglied beenden wird CI
22.02. Lincoln Pharmaceuticals Limited gibt den Rücktritt von Meha Patel als nicht-exekutives unabhängiges weibliches Verwaltungsratsmitglied bekannt CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Lincoln Pharmaceuticals Limited Announces Pirabhai Suthar Will Cease to Be an Independent Director
Lincoln Pharmaceuticals Limited Announces Resignation of Meha Patel as Non-Executive Independent women Director
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Lincoln Pharmaceuticals Limited Declares Dividend for the Financial Year 2022-23
Lincoln Pharmaceuticals Limited Proposes Dividend for the Financial Year 2022-2023
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Lincoln Pharmaceuticals Limited Recommends A Dividend for the Year Ended March 31, 2023
Lincoln Pharmaceuticals Limited Approves the Resignation of Anand A. Patel from the Position of Whole Time Director as Well as Director of the Company
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Lincoln Pharmaceuticals Limited Informs About Demise of Shri Ishwarlal Ambalal Patel Independent Director
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Lincoln Pharmaceuticals Limited Appoints Trusha Shah as Company Secretary and Compliance Officer
Lincoln Pharmaceuticals Limited Approves to Declare Dividend for the Financial Year 2021-22
Lincoln Pharmaceuticals Limited Proposes to Declare Dividend for the Financial Year 2021-2022
Lincoln Pharmaceuticals Limited Approves Appointment of Anand A. Patel as an Additional and Whole Time Director
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Lincoln Pharmaceuticals Limited Announces Resignation of Niren A. Desai as Company Secretary / Compliance Officer, with Effect from July 19, 2022
Lincoln Pharmaceuticals : Newspaper Advertisements
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2P91J Aktie
  4. A2P91J Aktie
  5. Nachrichten Lincoln Pharmaceuticals Limited
  6. Andere Sprachen